The iPROVE-O2 trial aims at comparing the efficacy of high and conventional FiO2 within a perioperative individualized ventilatory strategy to reduce the overall incidence of SSI.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
756
High FiO2 with a perioperative open lung strategy
Conventional FiO2 with a perioperative open lung strategy
Department of Anesthesia and Critical Care; Hospital Clinico Universitario
Valencia, Spain
RECRUITINGSurgical site infection
Time frame: seven postoperative days
Systemic complications
Time frame: seven postoperative days
Pulmonary complications
Time frame: seven postoperative days
Systemic and pulmonary complications
Time frame: thirty postoperative days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.